MedTrace Logo

The Effect of Salutogenic Model-Based Care on Mothers of Children Suffering From Febrile Illness

NCT07265401 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-12-11

No results posted yet for this study

Summary

This study was designed as an experimental study with pre-test-post-test comparisons and control groups, in order to investigate the effects of salutogenic model-based care on the individual integrity and coping attitudes of mothers with febrile children.

Conditions

  • Mothers

Interventions

OTHER

Salutogenic Care Model Training Program

Salutogenic Care Model Training Program This is a training program that involves meeting with the salutogenic care model in 3 sessions, providing both fever-related training and completing forms. 1. st Interview: Comprehensibility phase; This includes providing the mother with information about fever, ensuring that she is informed about fever, the cause of fever and what she should do. 2. nd Interview: Management phase; This includes ensuring that the mother knows which practices are effective in cases of fever, the amount, timing and frequency of medication administration, and the complications that may develop if the fever is not treated correctly. 3. rd Interview: Meaningfulness phase; This includes ensuring that the mother does not panic during a fever, preventing her fears, and reducing her anxiety because she knows how to approach a feverish child.

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Ayça Demir Yıldırım, PhD · Üsküdar University

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-05-01
Completion
2025-01-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07265401 on ClinicalTrials.gov